Company intelligence / Profile preview

medudoc Group

Berlin, Berlin, Germanyde.linkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

Clinical studies and randomized controlled trials with university hospitals have shown that the use of the medudoc platform significantly reduces time spent on informed consent processes by up to 77%, increases patient satisfaction, and improves legal compliance in clinical workflows. The solution has been scaled to three countries and dozens of hospitals, serving over 1.5 million annual patients as of early 2023.

Modalities: Non-pharmacological therapy (digital patient education platform)Non-pharmacological therapy (digital health software/SaaS)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Multiple hospital/clinic partners in DACH region for pilot programs and clinical validation; specific names not disclosed but includes university hospitals such as Kantonsspital St. Gallen and Klinikum Saarbrücken based on testimonials.

Beyond the preview

Go deeper on medudoc Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on medudoc Group.

Explore the full profile